Machine Learning

Empire Genomics & Molecular Instruments launch NISH, a fully automated system promising faster, clearer RNA-ISH results by preserving precious tissue samples.

The strategic acquisition merges a leading charge point management system with a vast payment network, creating a unified solution for EV fleet operators.

A new 'Buy' rating from a major bank subsidiary shines a light on SMAIO's data-driven approach to complex spine surgery. Here's why investors are noticing.

The global partner secures dual Atlassian Partner of the Year awards, highlighting its strategic AI integration and a fourth consecutive win in APAC services.

Formerly IGT Solutions, Atain sheds its outsourcing label to become an 'Enterprise Orchestration Partner,' promising assured outcomes with AI.

With a new APAC director, AI-pioneer TravelX aims to revolutionize airline revenue in Asia, turning static bookings into dynamic, profitable opportunities.

As Edifier celebrates 30 years, see how strategic acquisitions, vertical integration, and a vision for connected audio transformed it into a global force.

Medical tech giant Convatec unveils a new arsenal of advanced wound care solutions, using nitric oxide and placental tech to combat hard-to-heal injuries.

Causal Dynamics Lab’s Cielara Code is outperforming giants by fixing a core flaw: AI agents can write code, but they can’t find where to put it.

Lighthouse Autism Center is opening a new facility, promising to reduce wait times and provide integrated diagnostic and ABA therapy for local families.

As FDA rules on peptides shift, a new AI platform aims to give doctors clarity, separating solid science from speculation in the booming longevity market.

Linea's ZK rollup stack is now Lineth, a new Linux Foundation project. The move signals a major shift towards vendor-neutral governance for Ethereum scaling.

With six new collaborations, the life science leader aims to tame data complexity and accelerate discovery by creating a single, integrated software ecosystem.

Tunnell Consulting's perfect CMMC score reveals a cost-effective enclave strategy, challenging the belief that compliance must be an expensive overhaul.

With a novel 'NewCo' model and key partnerships, Banyan BioInnovations aims to de-risk and accelerate clinical-stage drugs past the funding valley of death.

A new report reveals a dramatic shift in Alzheimer's drug development, with 75% of trials now targeting pathways beyond amyloid for a new age of treatment.

A new wave of AI builds entire enterprise apps, but can it be trusted? WaveMaker's early success suggests its architecture-first approach is the key.

A new partnership moves AI from isolated tasks to integrated workflows, promising to solve the ROI problem that has plagued enterprise adoption.

Beijing has placed AI-powered robots at the core of its national strategy, aiming to reshape global manufacturing and accelerate a new technological race.

NImmune Biopharma's oral drug NIM-1324 shows promising safety and efficacy, targeting a novel pathway to treat IBD and a host of other diseases.